These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6101553)

  • 1. Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes.
    Molgó J; Lundh H; Thesleff S
    Eur J Pharmacol; 1980 Jan; 61(1):25-34. PubMed ID: 6101553
    [No Abstract]   [Full Text] [Related]  

  • 2. 4-Aminopyridine and evoked transmitter release from motor nerve endings.
    Illes P; Thesleff S
    Br J Pharmacol; 1978 Dec; 64(4):623-9. PubMed ID: 31961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.
    Lundh H; Thesleff S
    Eur J Pharmacol; 1977 Apr; 42(4):411-2. PubMed ID: 15849
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative activities of tetanus and botulinum toxins.
    Mellanby J
    Neuroscience; 1984 Jan; 11(1):29-34. PubMed ID: 6143282
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of anticholinesterase drugs on postjunctional potentials of skeletal muscle.
    Skliarov AI
    Gen Pharmacol; 1980; 11(1):89-95. PubMed ID: 6965920
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of new 4-aminopyridine derivatives on neuromuscular transmission and on smooth muscle contractility.
    Berger SG; Waser PG; Hofmann A
    Arzneimittelforschung; 1989 Jul; 39(7):762-5. PubMed ID: 2551304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the functional neuromuscular transmission unit.
    Stokes HB
    J Tenn Med Assoc; 1974 May; 67(5):399-403. PubMed ID: 4367687
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blockade of neuromuscular transmission by botulinum toxins on the sensitivity of skeletal muscle to acetylcholine in the frog [proceedings].
    Tonge DA; Wernig A
    J Physiol; 1978 Jul; 280():11P. PubMed ID: 211225
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve terminal facilitatory action of 4-aminopyridine: an analysis of the rising phase of the endplate potential.
    Jacobs RS; Burley ES
    Neuropharmacology; 1978 Jul; 17(7):439-44. PubMed ID: 692810
    [No Abstract]   [Full Text] [Related]  

  • 13. Restoration of transmitter release in botulinum-poisoned skeletal muscle.
    Lundh H; Cull-Candy SG; Leander S; Thesleff S
    Brain Res; 1976 Jun; 110(1):194-8. PubMed ID: 6127
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of 3,4-diaminopyridine and 4-aminopyridine in the anaesthetized cat.
    Durant NN; Nguyen N; Lee C; Katz RL
    Eur J Pharmacol; 1982 Oct; 84(3-4):215-9. PubMed ID: 6293848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitatory effects of 4-aminopyridine on strontium-mediated evoked and delayed transmitter release from motor nerve terminals.
    Molgó J; Lemeignan M; Guerrero S
    Eur J Pharmacol; 1982 Oct; 84(1-2):1-7. PubMed ID: 6128233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency dependent decrease of quantal content in a drug-treated neuromuscular junction.
    Volle RL
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(3):271-84. PubMed ID: 4354638
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and transmitter release.
    Cohen I; Van der Kloot W
    Int Rev Neurobiol; 1985; 27():299-336. PubMed ID: 2867980
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effect of kanamycin on evoked transmitter release. Reversal by 3,4-diaminopyridine.
    Molgó J; Lemeignan M; Uchiyama T; Lechat P
    Eur J Pharmacol; 1979 Jul; 57(1):93-7. PubMed ID: 38977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC; Thesleff S; Dasgupta BR
    Acta Physiol Scand; 1983; 119(2):127-33. PubMed ID: 6140815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.